Literature DB >> 9502455

Life-threatening parvovirus B19-associated myocarditis and cardiac transplantation as possible therapy: two case reports.

G Enders1, J Dötsch, J Bauer, W Nützenadel, H Hengel, D Haffner, G Schalasta, K Searle, K E Brown.   

Abstract

Parvovirus B19 infection can cause a wide spectrum of disease syndromes. Two cases of parvovirus B19 infection were identified that resulted in life-threatening myocarditis shortly after acute infection in immunocompetent individuals. The diagnosis was made with serological and polymerase chain reaction techniques. One patient was successfully treated by heart transplantation. Sequence analysis showed that the parvovirus B19 cloned from the patients' sera had 99% homology with the prototype sequence. Clinicians should be alerted to the possible role of parvovirus B19 in myocarditis presenting in immunocompetent patients.

Entities:  

Mesh:

Year:  1998        PMID: 9502455     DOI: 10.1086/516295

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  14 in total

1.  Fatal myocarditis associated with acute parvovirus B19 and human herpesvirus 6 coinfection.

Authors:  J Rohayem; J Dinger; R Fischer; K Klingel; R Kandolf; A Rethwilm
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

2.  Prevalence of parvovirus B19-specific antibodies and of viral DNA in patients with endogenous uveitis.

Authors:  Carsten Heinz; Annelie Plentz; Dirk Bauer; Arnd Heiligenhaus; Susanne Modrow
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-20       Impact factor: 3.117

3.  Phospholipase A2 activity-dependent stimulation of Ca2+ entry by human parvovirus B19 capsid protein VP1.

Authors:  Adrian Lupescu; C-Thomas Bock; Philipp A Lang; Susanne Aberle; Heike Kaiser; Reinhard Kandolf; Florian Lang
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

4.  Frequent detection of parvovirus B19 genome in the myocardium of adult patients with idiopathic dilated cardiomyopathy.

Authors:  Ulrich Lotze; Renate Egerer; Christiane Tresselt; Brigitte Glück; Gudrun Dannberg; Axel Stelzner; Hans R Figulla
Journal:  Med Microbiol Immunol       Date:  2003-12-20       Impact factor: 3.402

5.  Quantification of parvovirus B19 DNA using COBAS AmpliPrep automated sample preparation and LightCycler real-time PCR.

Authors:  Stefan Schorling; Gunnar Schalasta; Gisela Enders; Michael Zauke
Journal:  J Mol Diagn       Date:  2004-02       Impact factor: 5.568

Review 6.  Human parvovirus B19.

Authors:  Erik D Heegaard; Kevin E Brown
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

7.  Human parvovirus B19 associated dilated cardiomyopathy.

Authors:  Parul Jain; Amita Jain; Danish Nasar Khan; Mala Kumar
Journal:  BMJ Case Rep       Date:  2013-08-05

Review 8.  Molecular pathology of inflammatory cardiomyopathy.

Authors:  Karin Klingel; Martina Sauter; C Thomas Bock; Gudrun Szalay; Jens-Jörg Schnorr; Reinhard Kandolf
Journal:  Med Microbiol Immunol       Date:  2003-08-14       Impact factor: 3.402

9.  Fatal parvoviral myocarditis: a case report and review of literature.

Authors:  Fabio Tavora; Luis F Gonzalez-Cuyar; Jay S Dalal; Michael T O'Malley; Richard Zhao; Hong Q Peng; Allen P Burke
Journal:  Diagn Pathol       Date:  2008-04-30       Impact factor: 2.644

10.  Acute parvovirus B19 infection in pregnant women--an analysis of serial samples by serological and semi-quantitative PCR techniques.

Authors:  K Searle; C Guilliard; S Wallat; G Schalasta; G Enders
Journal:  Infection       Date:  1998 May-Jun       Impact factor: 7.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.